Water

Water

SCHEMBL2329935

C=CCOC(=O)C=O.O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL238622 0.97
SCHEMBL9540609 0.97
Sulfuric Acid SCHEMBL10682233 0.89 MAPT (0.44)
Glycolic Acid SCHEMBL10785328 0.87 MAPT (0.43)
SCHEMBL9338966 0.85 TSHR (0.42)
Water SCHEMBL1079113 0.82
SCHEMBL36139 0.79 MAPT (0.69)
SCHEMBL5167665 0.79 TSHR (0.54)
SCHEMBL19273 0.79
SCHEMBL6885967 0.79 MAPT (0.69)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1637538-B1 CRYSTALLINE CARBAPENEM INTERMEDIATE MEIJI SEIKA PHARMA CO LTD (JP) 2011-08-10 EP disclosed
US-7563901-B2 Intermediates of 2-substituted carbapenem derivatives and process for production thereof MEIJI SEIKA KAISHA, LTD. (JP) 2009-07-21 US disclosed
US-7524951-B2 Intermediates of 2-substituted carbapenem derivatives and process for production thereof MEIJI SEIKA KAISHA, LTD. (JP) 2009-04-28 US disclosed
US-20090082571-A1 Intermediates of 2-substituted carbapenem derivatives and process for production thereof SASAKI TOSHIRO 2009-03-26 US disclosed
US-7482445-B2 Crystalline carbapenem intermediate MEIJI SEIKA KAISHA, LTD. (JP) 2009-01-27 US disclosed
US-7468364-B2 Carbapenem compounds DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-12-23 US disclosed
CN-101255171-A Intermediates of 2-substituted carbapenem derivatives and process for production thereof MEIJI SEIKA KAISHA (JP) 2008-09-03 CN disclosed
US-20080167475-A1 Intermediates of 2-substituted carbapenem derivatives and process for production thereof SASAKI TOSHIRO 2008-07-10 US disclosed
US-20080076917-A1 Intermediates of 2-Substituted Carbapenem Derivatives and Process for Production Thereof MEIJI SEIKA KAISHA, LTD. (JP) 2008-03-27 US disclosed
CN-1330652-C Novel carbapenem compounds SUMITOMO PHARMA (JP) 2007-08-08 CN disclosed
EP-0061205-B1 2-PENEM COMPOUNDS; A METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM SCHERING CORPORATION (US) 1986-03-12 EP disclosed
EP-0140866-A1 Production of high purity alkyl glyoxylate Monsanto Company (US) 1985-05-08 EP disclosed
US-4502923-A AT VARYING PRESSURES MONSANTO COMPANY (US) 1985-03-05 US disclosed
US-4423055-A 6-Substituted-hydrocarbon-2-(substituted-thio)penem-3-carboxylic acids SCHERING CORPORATION (US) 1983-12-27 US disclosed
EP-0013662-B1 2-PENEM COMPOUNDS, A METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM SCHERING CORPORATION (US) 1983-04-13 EP disclosed
EP-0013663-B1 PROCESS FOR REMOVING AN ALLYLIC GROUP FROM ALLYLIC ESTERS, CARBONATES AND CARBAMATES SCHERING CORPORATION (US) 1982-11-17 EP disclosed
EP-0061205-A1 2-Penem compounds; a method for their preparation and pharmaceutical compositions comprising them SCHERING CORPORATION (US) 1982-09-29 EP disclosed
US-4314942-A Deprotection of allylic esters, carbonates and carbamates catalyzed by palladium compounds SCHERING CORPORATION (US) 1982-02-09 US disclosed
EP-0013663-A1 Process for removing an allylic group from allylic esters, carbonates and carbamates SCHERING CORPORATION (US) 1980-07-23 EP disclosed
EP-0013662-A1 2-Penem compounds, a method for their preparation and pharmaceutical compositions comprising them SCHERING CORPORATION (US) 1980-07-23 EP disclosed